PPARA and metabolic dysfunction-associated steatotic liver disease: In our study, we observed elevated phosphorylation levels of AMPK and changes in the expression of its downstream molecules, including SREBP‐1c, PPARα, CPT‐1, and FAS, following HP treatment in HCD‐fed NAFLD rats.